QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis
FRA:QIA - Deutsche Boerse Ag - NL0015002CX3 - Common Stock - Currency: EUR
QIA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 19 industry peers in the Life Sciences Tools & Services industry. QIA has an excellent financial health rating, but there are some minor concerns on its profitability. QIA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
QIA had positive earnings in the past year.
QIA had a positive operating cash flow in the past year.
QIA had positive earnings in each of the past 5 years.
In the past 5 years QIA always reported a positive cash flow from operatings.
1.2 Ratios
QIA has a Return On Assets (1.47%) which is comparable to the rest of the industry.
QIA has a Return On Equity of 2.34%. This is in the lower half of the industry: QIA underperforms 68.42% of its industry peers.
QIA has a Return On Invested Capital of 7.14%. This is in the better half of the industry: QIA outperforms 68.42% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QIA is in line with the industry average of 7.38%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROIC | 7.14% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
QIA has a Profit Margin (4.23%) which is comparable to the rest of the industry.
QIA's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 25.02%, QIA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
QIA's Operating Margin has improved in the last couple of years.
The Gross Margin of QIA (63.82%) is better than 89.47% of its industry peers.
In the last couple of years the Gross Margin of QIA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.02% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.82% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QIA is destroying value.
Compared to 1 year ago, QIA has less shares outstanding
QIA has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, QIA has an improved debt to assets ratio.
2.2 Solvency
QIA has an Altman-Z score of 4.54. This indicates that QIA is financially healthy and has little risk of bankruptcy at the moment.
QIA has a Altman-Z score of 4.54. This is amongst the best in the industry. QIA outperforms 100.00% of its industry peers.
QIA has a debt to FCF ratio of 2.77. This is a good value and a sign of high solvency as QIA would need 2.77 years to pay back of all of its debts.
The Debt to FCF ratio of QIA (2.77) is better than 78.95% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that QIA is not too dependend on debt financing.
QIA has a Debt to Equity ratio of 0.38. This is in the better half of the industry: QIA outperforms 78.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Altman-Z | 4.54 |
ROIC/WACC0.93
WACC7.66%
2.3 Liquidity
A Current Ratio of 3.61 indicates that QIA has no problem at all paying its short term obligations.
QIA has a Current ratio of 3.61. This is amongst the best in the industry. QIA outperforms 100.00% of its industry peers.
A Quick Ratio of 3.09 indicates that QIA has no problem at all paying its short term obligations.
QIA has a better Quick ratio (3.09) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.95% over the past year.
Measured over the past years, QIA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.25% on average per year.
The Revenue has been growing slightly by 0.66% in the past year.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
3.2 Future
Based on estimates for the next years, QIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.10% on average per year.
The Revenue is expected to grow by 7.82% on average over the next years.
EPS Next Y8.4%
EPS Next 2Y8.51%
EPS Next 3Y8.96%
EPS Next 5Y9.1%
Revenue Next Year4.26%
Revenue Next 2Y5.22%
Revenue Next 3Y5.83%
Revenue Next 5Y7.82%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 20.86, the valuation of QIA can be described as rather expensive.
84.21% of the companies in the same industry are more expensive than QIA, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.30, QIA is valued a bit cheaper.
QIA is valuated rather expensively with a Price/Forward Earnings ratio of 18.43.
73.68% of the companies in the same industry are more expensive than QIA, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.76. QIA is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.86 | ||
| Fwd PE | 18.43 |
4.2 Price Multiples
QIA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. QIA is cheaper than 63.16% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, QIA is valued a bit cheaper than the industry average as 63.16% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.64 | ||
| EV/EBITDA | 14.86 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QIA does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of QIA may justify a higher PE ratio.
PEG (NY)2.48
PEG (5Y)2.53
EPS Next 2Y8.51%
EPS Next 3Y8.96%
5. Dividend
5.1 Amount
With a yearly dividend of 0.52%, QIA is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.72, QIA pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.52, QIA pays less dividend than the S&P500 average, which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.51%
EPS Next 3Y8.96%
FRA:QIA (7/11/2025, 7:00:00 PM)
40.89
-1.02 (-2.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners86.78%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.86B
Analysts76.67
Price Target43.91 (7.39%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.23%
Min EPS beat(2)-3.85%
Max EPS beat(2)3.38%
EPS beat(4)3
Avg EPS beat(4)1.13%
Min EPS beat(4)-3.85%
Max EPS beat(4)3.38%
EPS beat(8)5
Avg EPS beat(8)1.25%
EPS beat(12)9
Avg EPS beat(12)4.32%
EPS beat(16)13
Avg EPS beat(16)5.2%
Revenue beat(2)0
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-0.02%
Revenue beat(8)0
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.09%
Revenue beat(16)7
Avg Revenue beat(16)0.75%
PT rev (1m)-2%
PT rev (3m)-5.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.65%
EPS NY rev (1m)0.31%
EPS NY rev (3m)2.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.86 | ||
| Fwd PE | 18.43 | ||
| P/S | 5.24 | ||
| P/FCF | 20.64 | ||
| P/OCF | 15.39 | ||
| P/B | 2.91 | ||
| P/tB | 12.37 | ||
| EV/EBITDA | 14.86 |
EPS(TTM)1.96
EY4.79%
EPS(NY)2.22
Fwd EY5.43%
FCF(TTM)1.98
FCFY4.84%
OCF(TTM)2.66
OCFY6.5%
SpS7.8
BVpS14.07
TBVpS3.31
PEG (NY)2.48
PEG (5Y)2.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROCE | 9.62% | ||
| ROIC | 7.14% | ||
| ROICexc | 9.2% | ||
| ROICexgc | 29.06% | ||
| OM | 25.02% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.82% | ||
| FCFM | 25.39% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Debt/EBITDA | 1.92 | ||
| Cap/Depr | 84.24% | ||
| Cap/Sales | 8.66% | ||
| Interest Coverage | 20.47 | ||
| Cash Conversion | 96.47% | ||
| Profit Quality | 600.91% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 | ||
| Altman-Z | 4.54 |
F-Score7
WACC7.66%
ROIC/WACC0.93
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
EPS Next Y8.4%
EPS Next 2Y8.51%
EPS Next 3Y8.96%
EPS Next 5Y9.1%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
Revenue Next Year4.26%
Revenue Next 2Y5.22%
Revenue Next 3Y5.83%
Revenue Next 5Y7.82%
EBIT growth 1Y11.16%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year58.48%
EBIT Next 3Y22.89%
EBIT Next 5Y16.26%
FCF growth 1Y69.33%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y46.6%
OCF growth 3Y1.77%
OCF growth 5Y15.28%